Physician-guided support for desire, arousal, and hormonal wellness.
TransformRX offers individualized sexual-wellness protocols designed around your symptoms, medical history, medications, hormonal health, and treatment goals. Depending on clinical appropriateness, a plan may include PT-141 or Kisspeptin.
Schedule a Consultation
Sexual health can involve multiple biological pathways.
Changes in libido, arousal, sexual performance, or reproductive function may be influenced by hormones, medications, stress, sleep, cardiovascular health, mood, menopause, fertility concerns, or other medical factors. Treatment begins with an evaluation to identify the most appropriate approach.
Libido Support
PT-141 is used in protocols focused on sexual desire and arousal in both women and men.
Central Nervous System Pathways
PT-141 acts through melanocortin receptors involved in desire and arousal rather than relying only on vascular or hormonal pathways.
Reproductive-Axis Support
Kisspeptin is associated with hypothalamic signaling involved in fertility, reproductive hormones, and libido support.
Care designed around your sexual-health goals.
Depending on your consultation, a personalized plan may focus on one or more of the following:
Libido Support
Support for reduced sexual desire in appropriate candidates.
Arousal Function
Support for central pathways involved in sexual arousal.
Female Sexual Wellness
PT-141 may be considered for selected women with hypoactive sexual desire disorder.
Male Sexual Wellness
Support for libido and arousal concerns when clinically appropriate.
Reproductive Signaling
Kisspeptin may support hypothalamic-pituitary-gonadal axis signaling.
Hormonal Evaluation
Hormone levels, medications, menopause, fertility, and other factors may be reviewed.
PT-141 and Kisspeptin support different aspects of sexual health.
PT-141 is primarily associated with central nervous system pathways involved in desire and arousal. Kisspeptin is associated with the hypothalamic reproductive axis and may support hormonal and fertility signaling.
Central Arousal Pathways
PT-141 activates melanocortin receptors involved in arousal and desire and does not depend solely on vascular pathways.
Reproductive-Axis Signaling
Kisspeptin acts through hypothalamic pathways involved in reproductive hormone release, fertility, and libido.
Personalized Selection
The right therapy depends on whether the primary concern is desire, arousal, reproductive signaling, hormonal balance, or another underlying medical issue.
Explore the therapies in this support category.
These therapies are not interchangeable. Their indications, evidence, administration, and suitability differ. A TransformRX clinician determines which option, if any, may be appropriate.
PT-141 / Bremelanotide
PT-141, also known as Bremelanotide, is a synthetic peptide derived from alpha-melanocyte-stimulating hormone. It is studied for its potential to support sexual wellness by activating melanocortin receptors involved in arousal and desire.
Kisspeptin
Kisspeptin is a hypothalamic reproductive-axis peptide associated with hormonal and libido support. It is used in clinician-directed protocols focused on fertility and reproductive function.
Matching the option to the clinical goal.
This comparison is educational only. Final selection depends on your medical history, symptoms, medications, hormone status, contraindications, and clinician assessment.
| Goal | Therapy Commonly Considered | Primary Area of Support |
|---|---|---|
| Reduced Sexual Desire | PT-141 | Central libido and desire pathways |
| Arousal Support | PT-141 | Melanocortin-receptor signaling in the nervous system |
| Female HSDD | PT-141 | FDA-approved indication in selected premenopausal women |
| Reproductive-Axis Support | Kisspeptin | Hypothalamic and reproductive-hormone signaling |
| Fertility-Related Support | Kisspeptin | Hormonal and reproductive pathways |
Treatment begins with a private medical assessment.
Sexual-health concerns can reflect hormonal, cardiovascular, neurologic, medication-related, relationship, or psychological factors. A respectful and confidential consultation helps identify the most appropriate next step.
Low Sexual Desire
Patients experiencing persistent loss of libido may be evaluated for hormonal, medication-related, and other contributing factors.
Arousal Concerns
PT-141 may be discussed when the primary concern involves central arousal or desire pathways.
Reproductive Goals
Kisspeptin may be considered in specialized protocols involving reproductive-hormone signaling or fertility support.
Your plan is built through confidential medical guidance.
Sexual wellness is highly individual. Treatment begins with a respectful review of symptoms, medications, hormone status, health history, relationship context, and treatment goals.
1. Private Consultation
Discuss libido, arousal, reproductive concerns, medications, and goals in a confidential setting.
2. Clinical Review
Hormones, cardiovascular health, medications, fertility factors, and contraindications may be reviewed.
3. Personalized Plan
Your clinician determines whether PT-141, Kisspeptin, or another approach is appropriate.
4. Follow-Up
Response, tolerance, satisfaction, and treatment goals are reassessed over time.
Physician supervision is essential.
PT-141 has an FDA-approved indication for hypoactive sexual desire disorder in certain premenopausal women, while other uses may be off-label. Kisspeptin may be investigational or compounded depending on the formulation and treatment goal. Eligibility should be determined through appropriate screening and informed consent.
Cardiovascular review matters: Blood pressure, heart history, and other risk factors may affect candidacy for PT-141.
Pregnancy and fertility goals matter: Reproductive status and treatment objectives must be discussed before therapy.
No self-adjustment: Dose, timing, and frequency should only be changed by the prescribing clinician.
Common questions, clearly answered.
Begin with a private and thoughtful medical evaluation.
Schedule Your Consultation
Meet with the TransformRX team to discuss sexual-wellness concerns, hormonal health, medications, reproductive goals, and whether a physician-guided protocol may be appropriate.
Prepare for Your Visit
Bring a current medication and supplement list, recent hormone or laboratory results, and details about when your symptoms began and how they affect your quality of life.
Restore confidence with a plan built around you.
Schedule a confidential consultation to explore physician-guided options for libido, arousal, reproductive signaling, and hormonal wellness.
Schedule a ConsultationImportant Clinical Notice
The information on this page is for education only and is not a diagnosis or treatment recommendation. PT-141 has a specific FDA-approved indication, while other uses may be off-label. Kisspeptin may be investigational, compounded, or used off-label depending on the clinical purpose. Availability and eligibility are determined through physician evaluation, informed consent, and ongoing monitoring.